Inventor · disambiguated record
Christopher John Hamilton Porter
Also filed as: PORTER CHRISTOPHER · PORTER CHRISTOPHER JOHN · PORTER CHRISTOPHER JOHN HAMILT · PORTER CHRISTOPHER JOHN HAMILTON
12 granted patents·15 pending applications·55 citations·filing 1997–2025
88Inventor score
Files withPURETECH LYT INC9UNIV MONASH6ENDOSOME THERAPEUTICS INC3KRIPPNER GUY YEOMAN2STARPHARMA PTY LTD2
Top patents by PatentIndex Score
27 records- 0185US8586705B2Macromolecular compounds having controlled stoichiometryKRIPPNER GUY YEOMAN·Filed 2012·Granted Nov 19, 2013·7 cites·30 claims
- 0283US2024050573A1Lymph directing prodrugsUNIV MONASH·Filed 2023·Application pending·0 cites
- 0381US2025325671A1Lymph directing prodrugsUNIV MONASH·Filed 2025·Application pending·0 cites
- 0480US11975073B2Lipid prodrugs of neurosteroidsPURETECH LYT INC·Filed 2023·Granted May 7, 2024·0 cites·15 claims
- 0579US11883497B2Lymphatic system-directing lipid prodrugsPURETECH LYT INC·Filed 2018·Granted Jan 30, 2024·2 cites·10 claims
- 0677US2024245788A1Lipid prodrugs of neurosteroidsPURETECH LYT INC·Filed 2024·Application pending·0 cites
- 0776US8703116B2Modified macromoleculeSTARPHARMA PTY LTD·Filed 2012·Granted Apr 22, 2014·4 cites·12 claims
- 0873US8337823B2Modified macromoleculeBOYD BENJAMIN JAMES·Filed 2006·Granted Dec 25, 2012·5 cites·53 claims
- 0973US8258259B2Macromolecular compounds having controlled stoichiometryKRIPPNER GUY YEOMAN·Filed 2006·Granted Sep 4, 2012·3 cites·14 claims
- 1072US2022395513A1Lipid prodrugs of neurosteroidsPURETECH LYT INC·Filed 2022·Application pending·0 cites
- 1171US2025312461A1Lymph directing prodrugsUNIV MONASH·Filed 2025·Application pending·0 cites
- 1269US2025235544A1Tripartite Modulators of Endosomal G Protein-Coupled ReceptorsENDOSOME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1368US11304954B2Lipid prodrugs of mycophenolic acid and uses thereofPURETECH LYT INC·Filed 2018·Granted Apr 19, 2022·1 cites·20 claims
- 1468US2019105299A1Lymph directing prodrugsUNIV MONASH·Filed 2018·Application pending·0 cites
- 1567US5968987AHalofantrine free base for the treatment of malaria and compositionsSMITHKLINE BEECHAM PLC·Filed 1997·Granted Oct 19, 1999·32 cites·8 claims
- 1664US12178875B2Lymphatic system-directing lipid prodrugsSEAPORT THERAPEUTICS INC·Filed 2024·Granted Dec 31, 2024·0 cites·11 claims
- 1762US11938137B2Lipid prodrugs of mycophenolic acid and uses thereofPURETECH LYT INC·Filed 2022·Granted Mar 26, 2024·0 cites·20 claims
- 1862US2021268115A1Lipid prodrugs of neurosteroidsPURETECH LYT INC·Filed 2021·Application pending·0 cites
- 1961US11324832B2Tripartite modulators of endosomal G protein-coupled receptorsENDOSOME THERAPEUTICS INC·Filed 2016·Granted May 10, 2022·1 cites·10 claims
- 2061US2023119819A1Tripartite Modulators of Endosomal G Protein-Coupled ReceptorsENDOSOME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2151US2022273807A1Conjugates for use in methods of treating cancerASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 2250US2025152550A1Lymph-targeting formulationsUNIV MONASH·Filed 2021·Application pending·0 cites
- 2347US2022339168A1Methods and compounds for treatment of metabolic diseaseUNIV MONASH·Filed 2020·Application pending·0 cites
- 2443US2022288216A1Targeted dendrimer conjugatesSTARPHARMA PTY LTD·Filed 2020·Application pending·0 cites
- 2543US2020345646A1Liquid filled formulations of pde5 inhibitorsMW ENCAP LTD·Filed 2018·Application pending·0 cites
- 2640US2021300962A1Lipid prodrugs of pregnane neurosteroids and uses thereofPURETECH LYT INC·Filed 2019·Application pending·0 cites
- 2738US11608345B1Lipid prodrugs of rapamycin and its analogs and uses thereofPURETECH LYT INC·Filed 2018·Granted Mar 21, 2023·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →